Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 39 News Items found Out of the Lab and into the World: The Endoscopic Laser Scalpel Thursday, December 1, 2011 A prototype of an innovative device developed at Memorial Sloan Kettering for minimally invasive surgery in head, neck, and other cancers in confined spaces holds promise for helping patients around the globe. Memorial Sloan Kettering Among the Top “Best Hospitals” for Cancer Care and Ranked First in Gynecology by U.S News & World Report Tuesday, July 30, 2019 Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology. New MSK Radiation Approach Means Fewer Side Effects for More Patients with HPV-Related Head and Neck Cancer Thursday, January 20, 2022 A low-dose radiation approach could help more patients avoid side effects of treatment for head and neck cancer. Top Cancer Research Advances at MSK in 2025 Monday, December 15, 2025 MSK researchers continued to make strides against cancer in 2025. Learn about some of their top discoveries. This Remarkable MSK Patient Is Living With Two Kinds of Stage 4 Cancer Thursday, December 5, 2024 Learn how it's possible to stay active even with two types of advanced cancer — lung cancer and mantle cell lymphoma — thanks to innovative treatments at MSK. Q&A What Should I Know about Barrett’s Esophagus and Risk for Esophageal Cancer? Friday, July 10, 2020 Learn about a heartburn-related condition called Barrett’s esophagus and its connection to a higher risk of esophageal cancer. Announcement MSK Issues Joint Statement Urging Use of HPV Vaccine to Prevent Cancers Wednesday, January 27, 2016 MSK joins other leading cancer institutions in calling for increased vaccination to protect against human papillomavirus, which causes many forms of cancer. Feature Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients Thursday, December 1, 2011 Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments. Finding Cancers Caused by HPV Respond Better to Treatment — a New Study Helps Explain Why Thursday, January 30, 2020 According to Memorial Sloan Kettering scientists, it has to do with what the virus does to a cell’s DNA repair machinery. In the Clinic T Cell Therapies Offer a New Way to Treat Gynecologic Cancers Wednesday, September 30, 2020 MSK is a leader in developing new types of immunotherapy for gynecologic cancers, including tumors of the cervix, ovaries, and uterus. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment